Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Non Operating Income (2020 - 2025)

Beam Therapeutics (BEAM) has disclosed Non Operating Income for 6 consecutive years, with $261.7 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 2603.11% to $261.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $303.7 million through Dec 2025, up 681.43% year-over-year, with the annual reading at $303.7 million for FY2025, 681.43% up from the prior year.
  • Non Operating Income for Q4 2025 was $261.7 million at Beam Therapeutics, up from $14.1 million in the prior quarter.
  • The five-year high for Non Operating Income was $261.7 million in Q4 2025, with the low at -$17.3 million in Q2 2021.
  • Average Non Operating Income over 5 years is $24.4 million, with a median of $10.0 million recorded in 2022.
  • The sharpest move saw Non Operating Income tumbled 117.81% in 2021, then skyrocketed 4322.08% in 2022.
  • Over 5 years, Non Operating Income stood at -$1.2 million in 2021, then surged by 4322.08% to $51.6 million in 2022, then tumbled by 78.11% to $11.3 million in 2023, then dropped by 14.35% to $9.7 million in 2024, then surged by 2603.11% to $261.7 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $261.7 million, $14.1 million, and $17.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.